drugset / Trial / NCT02033317
An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis
NaSingle-groupOpen-labelTreatment
Summary
This study assessed the pharmacodynamic effects of patiromer on serum potassium in participants on hemodialysis.
Timeline
- Start
- 2008-08
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Patiromer | Other / unclassified | 5 g | Oral |
Indications
No indication recorded.